In the News
Shire to combine with Baxalta in £22bn deal
Graham Watson
12th January 2016
More merger activity in the pharmaceutical sector as Shire and Baxalta confirm their £22billion merger, creating a giant market leader in the treatment of rare diseases.
You might also like

Why is Ryanair so profitable?
1st February 2023

How is Tesco so profitable?
29th January 2023
Why is Tesco so profitable?
Study Notes

Business Economics: $1 Million Per Day To Run a Cruise Ship
27th December 2022

Hearing Aids Merger Under CMA Investigation
6th December 2022

Penguin Scraps Merger Plan with Rival Publisher
22nd November 2022

Business Growth: Lidl's UK Profits Quadruple
17th November 2022